* Aspen Aerogels Inc ASPN.N ASPN.K is expected to show a
rise
in quarterly revenue when it reports results on February 15.
* The Northborough Massachusetts-based company is expected
to
report a 82.5% increase in revenue to $57.453 million from
$31.48 million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Aspen Aerogels Inc
is for
a loss of 30 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aspen
Aerogels
Inc is $26, above its last closing price of $10.80.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.57 -0.57 -0.75 Missed -31.7
Jun. 30 2022 -0.61 -0.57 -0.68 Missed -18.4
Mar. 31 2022 -0.49 -0.48 -0.59 Missed -23.2
Dec. 31 2021 -0.29 -0.29 -0.50 Missed -72.4
Sep. -0.25 -0.25 -0.36 Missed -42.2
30 2021
Jun. 30 2021 -0.28 -0.27 -0.23 Beat 15.9
Mar. 31 2021 -0.20 -0.20 -0.22 Missed -8.6
Dec. 31 2020 -0.15 -0.15 -0.23 Missed -57.5
This summary was machine generated February 14 at 03:01 GMT.
All figures in US dollars unless otherwise stated